Pub Date : 2025-04-01Epub Date: 2025-03-17DOI: 10.1016/j.rgmx.2024.12.005
J.A. Torres-Díaz, I. García-Juárez
{"title":"¿Debe ser micofenolato de mofetilo el tratamiento de primera línea en la hepatitis autoinmune?","authors":"J.A. Torres-Díaz, I. García-Juárez","doi":"10.1016/j.rgmx.2024.12.005","DOIUrl":"10.1016/j.rgmx.2024.12.005","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 323-325"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-03-13DOI: 10.1016/j.rgmx.2024.12.003
R.I. Carmona-Sánchez , G. Vázquez-Elizondo , M.C. Rodríguez-Leal , O. Gómez-Escudero , M.V. Bielsa-Fernández , E. Coss-Adame , K. García-Zermeño , P. Gómez-Castaños , M. Morales-Arámbula , E.C. Morel-Cerda , A. Noble-Lugo , J.M. Remes-Troche , S. Solórzano-Olmos , O.E. Trujillo-Benavides , M.A. Valdovinos-Díaz , L.R. Valdovinos-García
Introduction and aims
Functional dyspepsia (FD) is a highly prevalent condition characterized by upper gastrointestinal symptoms with no apparent organic cause. It is a complex and multifactorial disease that frequently overlaps with other disorders of gut-brain interaction. It is recurrent, has a variable therapeutic response, and affects patient quality of life. Our aim was to formulate good practice recommendations for the management of FD through a consensus review of the disease, updating and complementing the 2017 consensus on dyspepsia from the Asociación Mexicana de Gastroenterología (AMG).
Methods
Sixteen experts summoned by the AMG carried out a literature review (2017-2024) and formulated good clinical practice recommendations for the diagnosis and treatment of FD. They were discussed until reaching a consensus, and the most recent evidence on the theme was evaluated, utilizing the GRADE system.
Results
Twenty-three good clinical practice recommendations for the management of FD were developed that addressed the following aspects: 1) definition, pathophysiology, and epidemiology; 2) diagnosis; 3) nonpharmacologic treatment; 4) Helicobacter pylori eradication; 5) antisecretory and anti-acid therapy; and 6) prokinetics and neuromodulators.
Conclusions
The FD is one of the most frequent gastrointestinal conditions seen in daily practice. We present good clinical practice recommendations for the specific management of this disorder, taking into account the most recent advances that complement and update the consensus on dyspepsia published by the AMG in 2017.
简介和目的功能性消化不良（FD）是一种非常普遍的疾病，以上消化道症状为特征，无明显的器质性病因。它是一种复杂的多因素疾病，经常与其他肠脑相互作用疾病重叠。它是反复发作的，有不同的治疗反应，并影响患者的生活质量。我们的目标是通过对该疾病的共识审查制定FD管理的良好实践建议，更新和补充Asociación Mexicana de Gastroenterología (AMG) 2017年关于消化不良的共识。方法由AMG召集的16位专家进行文献综述（2017-2024），并制定FD诊断和治疗的良好临床实践建议。他们进行了讨论，直到达成共识，并利用GRADE系统评估了有关该主题的最新证据。结果针对FD的定义、病理生理学和流行病学，提出了23项临床管理建议；2)诊断;3)非药物治疗；4)幽门螺杆菌根除；5)抗分泌抗酸治疗；6)原动力学和神经调节剂。结论FD是临床上最常见的胃肠道疾病之一。考虑到AMG在2017年发布的关于消化不良共识的最新进展，我们提出了针对该疾病具体管理的良好临床实践建议。
{"title":"Recomendaciones de buena práctica clínica en el diagnóstico y tratamiento de la dispepsia funcional. Revisión de expertos de la Asociación Mexicana de Gastroenterología","authors":"R.I. Carmona-Sánchez , G. Vázquez-Elizondo , M.C. Rodríguez-Leal , O. Gómez-Escudero , M.V. Bielsa-Fernández , E. Coss-Adame , K. García-Zermeño , P. Gómez-Castaños , M. Morales-Arámbula , E.C. Morel-Cerda , A. Noble-Lugo , J.M. Remes-Troche , S. Solórzano-Olmos , O.E. Trujillo-Benavides , M.A. Valdovinos-Díaz , L.R. Valdovinos-García","doi":"10.1016/j.rgmx.2024.12.003","DOIUrl":"10.1016/j.rgmx.2024.12.003","url":null,"abstract":"<div><h3>Introduction and aims</h3><div>Functional dyspepsia (FD) is a highly prevalent condition characterized by upper gastrointestinal symptoms with no apparent organic cause. It is a complex and multifactorial disease that frequently overlaps with other disorders of gut-brain interaction. It is recurrent, has a variable therapeutic response, and affects patient quality of life. Our aim was to formulate good practice recommendations for the management of FD through a consensus review of the disease, updating and complementing the 2017 consensus on dyspepsia from the <em>Asociación Mexicana de Gastroenterología</em> (AMG).</div></div><div><h3>Methods</h3><div>Sixteen experts summoned by the AMG carried out a literature review (2017-2024) and formulated good clinical practice recommendations for the diagnosis and treatment of FD. They were discussed until reaching a consensus, and the most recent evidence on the theme was evaluated, utilizing the GRADE system.</div></div><div><h3>Results</h3><div>Twenty-three good clinical practice recommendations for the management of FD were developed that addressed the following aspects: 1) definition, pathophysiology, and epidemiology; 2) diagnosis; 3) nonpharmacologic treatment; 4) <em>Helicobacter pylori</em> eradication; 5) antisecretory and anti-acid therapy; and 6) prokinetics and neuromodulators.</div></div><div><h3>Conclusions</h3><div>The FD is one of the most frequent gastrointestinal conditions seen in daily practice. We present good clinical practice recommendations for the specific management of this disorder, taking into account the most recent advances that complement and update the consensus on dyspepsia published by the AMG in 2017.</div></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 227-251"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2024-12-24DOI: 10.1016/j.rgmx.2024.09.009
G.R. Medina-Murillo , U. Rodríguez-Medina , U. Rodríguez-Wong
{"title":"Pseudoangiosarcoma de Masson de localización perianal. Una entidad poco común","authors":"G.R. Medina-Murillo , U. Rodríguez-Medina , U. Rodríguez-Wong","doi":"10.1016/j.rgmx.2024.09.009","DOIUrl":"10.1016/j.rgmx.2024.09.009","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 309-310"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-04-08DOI: 10.1016/j.rgmx.2025.01.006
F. Higuera-de-la-Tijera, F. Lajud-Barquín, A. Tovar-Aguilar
{"title":"Respuesta a Hinpetch Daungsupawong et al. respecto a «Cambios de peso y modificaciones de estilo de vida implementados durante el confinamiento por la pandemia COVID-19: Correspondencia»","authors":"F. Higuera-de-la-Tijera, F. Lajud-Barquín, A. Tovar-Aguilar","doi":"10.1016/j.rgmx.2025.01.006","DOIUrl":"10.1016/j.rgmx.2025.01.006","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 339-341"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-05-09DOI: 10.1016/j.rgmx.2025.01.007
E. Murcio-Pérez, I. Bartnicki-Navarrete, J.C. Pintor-Belmontes, O.M. Solórzano-Pineda, O.V. Hernández-Mondragón
{"title":"Gastroyeyunostomía guiada por ultrasonido endoscópico para manejo de síndrome de pinzamiento de la arteria mesentérica superior: reporte de caso con seguimiento a 18 meses","authors":"E. Murcio-Pérez, I. Bartnicki-Navarrete, J.C. Pintor-Belmontes, O.M. Solórzano-Pineda, O.V. Hernández-Mondragón","doi":"10.1016/j.rgmx.2025.01.007","DOIUrl":"10.1016/j.rgmx.2025.01.007","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 327-329"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-05-19DOI: 10.1016/j.rgmx.2025.02.002
G. Renau , D. Abelló , F. Sabench , J. Doménech , A. Sánchez
Introduction
The Tokyo Guidelines for the severity classification of acute cholecystitis include leukocytosis as a severity classifier, without considering C-reactive protein (CRP). Our aim was to determine which of the 2 variables has a greater predictive capacity for local complications in acute cholecystitis (LCAC).
Material and methods
A retrospective single-center study was conducted on patients that underwent emergency cholecystectomy within the time frame of June 2022 and December 2023. The variables associated with LCAC were analyzed and a ROC analysis was carried out.
Results
The multivariate analysis of 145 patients identified the following associations with LCAC: CRP (p < 0.001; OR 11.8), AUC of 0.88 (p= 0.029), and cutoff point of 4 mg/dl (88% sensitivity, 71% specificity); leukocytosis (p = 0.031; OR 5), AUC of 0.81(p = 0.037), and cutoff point of 11.09 × 109/l (78% sensitivity, 70% specificity).
Conclusions
CRP may have a higher predictive capacity for LCAC than leukocytosis.
{"title":"Proteína C reactiva como predictor de colecistitis aguda complicada: Estudio de cohortes","authors":"G. Renau , D. Abelló , F. Sabench , J. Doménech , A. Sánchez","doi":"10.1016/j.rgmx.2025.02.002","DOIUrl":"10.1016/j.rgmx.2025.02.002","url":null,"abstract":"<div><h3>Introduction</h3><div>The Tokyo Guidelines for the severity classification of acute cholecystitis include leukocytosis as a severity classifier, without considering C-reactive protein (CRP). Our aim was to determine which of the 2<!--> <!-->variables has a greater predictive capacity for local complications in acute cholecystitis (LCAC).</div></div><div><h3>Material and methods</h3><div>A retrospective single-center study was conducted on patients that underwent emergency cholecystectomy within the time frame of June 2022 and December 2023. The variables associated with LCAC were analyzed and a ROC analysis was carried out.</div></div><div><h3>Results</h3><div>The multivariate analysis of 145 patients identified the following associations with LCAC: CRP (<em>p</em> <!--><<!--> <!-->0.001; OR 11.8), AUC of 0.88 (<em>p</em> <em>=</em> <!-->0.029), and cutoff point of 4<!--> <!-->mg/dl (88% sensitivity, 71% specificity); leukocytosis (<em>p</em> <!-->=<!--> <!-->0.031; OR 5), AUC of 0.81(<em>p</em> <!-->=<!--> <!-->0.037), and cutoff point of 11.09<!--> <!-->×<!--> <!-->10<sup>9</sup>/l (78% sensitivity, 70% specificity).</div></div><div><h3>Conclusions</h3><div>CRP may have a higher predictive capacity for LCAC than leukocytosis.</div></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 330-333"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-05-19DOI: 10.1016/j.rgmx.2025.02.003
R.A. Jiménez-Castillo , S. Arumugam , J.M. Remes-Troche , T. Venkatesan
Cannabinoid hyperemesis syndrome (CHS) is a chronic disorder characterized by episodes of severe vomiting, alternating with asymptomatic or minimally symptomatic periods. The episodes of emesis tend to be disabling, negatively affecting quality of life. The disorder's main characteristic is that it is associated with previous chronic heavy cannabis use. CHS is similar to cyclic vomiting syndrome (CVS), with the exception that the sustained cessation of cannabis use is expected to resolve the vomiting episodes.
The average time between the onset of acute CHS episodes and diagnosis ranges from three to six years, based on previously published cases. This delay in the diagnosis reflects a lack of awareness of the condition on the part of physicians. Delayed diagnosis of CHS results in frequent emergency room visits and increased healthcare costs, and the lack of effective treatment leads to poor patient outcomes. The diagnosis is challenging, and some authors have diagnosed CHS when patients had cyclic vomiting, in the context of chronic cannabis use, regardless of the duration of use or the potency of the product used.
The aim of this narrative review is to provide a detailed and critical analysis of current knowledge about CHS. The present document focuses on a thorough review of the literature on worldwide cannabis use, the role of the endocannabinoid system in the pathophysiology of CHS, diagnostic criteria, and current management of CHS.
{"title":"Síndrome de hiperémesis cannabinoide: una revisión","authors":"R.A. Jiménez-Castillo , S. Arumugam , J.M. Remes-Troche , T. Venkatesan","doi":"10.1016/j.rgmx.2025.02.003","DOIUrl":"10.1016/j.rgmx.2025.02.003","url":null,"abstract":"<div><div>Cannabinoid hyperemesis syndrome (CHS) is a chronic disorder characterized by episodes of severe vomiting, alternating with asymptomatic or minimally symptomatic periods. The episodes of emesis tend to be disabling, negatively affecting quality of life. The disorder's main characteristic is that it is associated with previous chronic heavy cannabis use. CHS is similar to cyclic vomiting syndrome (CVS), with the exception that the sustained cessation of cannabis use is expected to resolve the vomiting episodes.</div><div>The average time between the onset of acute CHS episodes and diagnosis ranges from three to six years, based on previously published cases. This delay in the diagnosis reflects a lack of awareness of the condition on the part of physicians. Delayed diagnosis of CHS results in frequent emergency room visits and increased healthcare costs, and the lack of effective treatment leads to poor patient outcomes. The diagnosis is challenging, and some authors have diagnosed CHS when patients had cyclic vomiting, in the context of chronic cannabis use, regardless of the duration of use or the potency of the product used.</div><div>The aim of this narrative review is to provide a detailed and critical analysis of current knowledge about CHS. The present document focuses on a thorough review of the literature on worldwide cannabis use, the role of the endocannabinoid system in the pathophysiology of CHS, diagnostic criteria, and current management of CHS.</div></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 214-226"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2024-08-23DOI: 10.1016/j.rgmx.2024.07.004
L.M. Sanabria-Arévalo , L.C. Domínguez-Torres , J. Kock , J.D. Lotero , J.C. Gómez-Cáceres , E. Tuta-Quintero
Introduction and aim
Acute appendicitis stands out as one of the most frequent surgically-treated diseases. Risk scales for acute appendicitis, such as the Alvarado and AIR scoring systems, show good diagnostic yield. The aim of our study was to compare the predictive capacity between the Alvarado and AIR scores in the diagnosis of acute appendicitis.
Methods
A cross-sectional study was conducted on patients that underwent appendectomy due to suspected acute appendicitis, confirmed by histopathology. The predictive capacity of the Alvarado and AIR scores was evaluated through an ROC curve analysis, determining the area under the ROC curve. The STROBE checklist was utilized.
Results
A total of 358 patients with clinical suspicion of acute appendicitis were included, 51% of whom were men (183/358). Median patient age was 36 years (IQR: 24-46). The ROC curve of the Alvarado score was 0.767 (95% CI: 0.716-0.818), and with a cutoff point of 0-4, had 78% sensitivity and 84% specificity. The AIR score had a ROC curve of 0.741 (95% CI: 0.691-0.788), and with a 0-4 cutoff point, 87% sensitivity and 56% specificity. There was no statistically significant difference between the 2 scores (p = 0.266).
Conclusion
The Alvarado and AIR scores have a similar predictive capacity for acute appendicitis. The low cutoff points of the risk scales are related to greater diagnostic sensitivity of the disease.
{"title":"Comparación de la capacidad predictiva de las escalas Alvarado y AIR en el diagnóstico de apendicitis aguda: un estudio prospectivo","authors":"L.M. Sanabria-Arévalo , L.C. Domínguez-Torres , J. Kock , J.D. Lotero , J.C. Gómez-Cáceres , E. Tuta-Quintero","doi":"10.1016/j.rgmx.2024.07.004","DOIUrl":"10.1016/j.rgmx.2024.07.004","url":null,"abstract":"<div><h3>Introduction and aim</h3><div>Acute appendicitis stands out as one of the most frequent surgically-treated diseases. Risk scales for acute appendicitis, such as the Alvarado and AIR scoring systems, show good diagnostic yield. The aim of our study was to compare the predictive capacity between the Alvarado and AIR scores in the diagnosis of acute appendicitis.</div></div><div><h3>Methods</h3><div>A cross-sectional study was conducted on patients that underwent appendectomy due to suspected acute appendicitis, confirmed by histopathology. The predictive capacity of the Alvarado and AIR scores was evaluated through an ROC curve analysis, determining the area under the ROC curve. The STROBE checklist was utilized.</div></div><div><h3>Results</h3><div>A total of 358 patients with clinical suspicion of acute appendicitis were included, 51% of whom were men (183/358). Median patient age was 36 years (IQR: 24-46). The ROC curve of the Alvarado score was 0.767 (95% CI: 0.716-0.818), and with a cutoff point of 0-4, had 78% sensitivity and 84% specificity. The AIR score had a ROC curve of 0.741 (95% CI: 0.691-0.788), and with a 0-4 cutoff point, 87% sensitivity and 56% specificity. There was no statistically significant difference between the 2 scores (p<!--> <!-->=<!--> <!-->0.266).</div></div><div><h3>Conclusion</h3><div>The Alvarado and AIR scores have a similar predictive capacity for acute appendicitis. The low cutoff points of the risk scales are related to greater diagnostic sensitivity of the disease.</div></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 176-181"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-10-10DOI: 10.1016/j.rgmx.2024.09.001
E.A. Montemayor-Garza , L. Santoyo-Fexas , M.I. Wah-Suárez , L.A. González-Torres , R.A. López-Pérez , S. Ramírez-Peña
{"title":"Hemobezoar causa obstrucción aguda de intestino delgado en un caso de úlcera péptica","authors":"E.A. Montemayor-Garza , L. Santoyo-Fexas , M.I. Wah-Suárez , L.A. González-Torres , R.A. López-Pérez , S. Ramírez-Peña","doi":"10.1016/j.rgmx.2024.09.001","DOIUrl":"10.1016/j.rgmx.2024.09.001","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 1","pages":"Pages 151-153"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143695983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2024-11-20DOI: 10.1016/j.rgmx.2024.07.008
J.E. Aquino-Matus , M. Figueroa-Palafox , C. Culebro-García , L.R. Valdovinos-García
{"title":"Síndrome de Wilkie con dilatación gástrica aguda y gas portal hepático","authors":"J.E. Aquino-Matus , M. Figueroa-Palafox , C. Culebro-García , L.R. Valdovinos-García","doi":"10.1016/j.rgmx.2024.07.008","DOIUrl":"10.1016/j.rgmx.2024.07.008","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 1","pages":"Pages 131-133"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143697034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号